Disclosed are new substituted oxazole and thiazole compounds of Formula (I) and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses thereof:
本发明涉及新的取代的
噁唑和
噻唑化合物(I式),以及其药学上可接受的盐、酯或前药,这些衍
生物与药学上可接受的载体的组合物,以及它们的用途。